Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Global Forecast 2024-2030

Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Global Forecast 2024-2030


The Radioimmunoassays Market size was estimated at USD 448.94 million in 2023 and expected to reach USD 468.61 million in 2024, at a CAGR 4.52% to reach USD 612.00 million by 2030.

Global Radioimmunoassays Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Radioimmunoassays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radioimmunoassays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Radioimmunoassays Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam Plc, ALPCO, Antigenix America, Inc., Berthold Technologies GmbH & Co.KG, Biosynth Ltd, BioVendor – Laboratorni medicina a.s., Creative Biomart, Inc., Danaher Corporation, Demeditec Diagnostics GmbH, Diasorine S.P.A., DRG International, Inc. by BioCheck Inc., Drive DeVilbiss International, EUROIMMUN Medizinische Labordiagnostika AG, Hidex Oy., IBL International GmbH, Immuno-Biological Laboratories, Inc., Institute of Isotopes Co. Ltd., LKB Instruments, LubioScience GmbH, Marin Biologic Laboratories, Inc., Merck & Co, Inc, Montreal Biotech Inc., MP Biomedicals, LLC, NovoLytix GmbH, Padyab Teb Co., and PerkinElmer Inc..

Market Segmentation & Coverage



This research report categorizes the Radioimmunoassays Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Coated-Tube RIA
Double-Antibody RIA
Product Type
Analyzers
Reagents & Kits
Application
Clinical Diagnostics
Research
End-User
Academic & Research Institutes
Clinical Diagnostic Laboratories
Hospitals
Pharmaceuticals & CROs
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Radioimmunoassays Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radioimmunoassays Market?
3. What are the technology trends and regulatory frameworks in the Radioimmunoassays Market?
4. What is the market share of the leading vendors in the Radioimmunoassays Market?
5. Which modes and strategic moves are suitable for entering the Radioimmunoassays Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Radioimmunoassays Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic and infectious disease
5.1.1.2. Increasing number of imaging centers across the globe
5.1.1.3. Rapid shift towards early diagnosis and surge in healthcare expenditure
5.1.2. Restraints
5.1.2.1. Short shelf life and associated hazards concern with radioactive materials
5.1.3. Opportunities
5.1.3.1. Surge in government funding for life science research activity
5.1.3.2. Integration of advanced technology for disease diagnostics
5.1.4. Challenges
5.1.4.1. Presence of alternative advanced immunoassays and the dearth of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Radioimmunoassays Market, by Type
6.1. Introduction
6.2. Coated-Tube RIA
6.3. Double-Antibody RIA
7. Radioimmunoassays Market, by Product Type
7.1. Introduction
7.2. Analyzers
7.3. Reagents & Kits
8. Radioimmunoassays Market, by Application
8.1. Introduction
8.2. Clinical Diagnostics
8.3. Research
9. Radioimmunoassays Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Clinical Diagnostic Laboratories
9.4. Hospitals
9.5. Pharmaceuticals & CROs
10. Americas Radioimmunoassays Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Radioimmunoassays Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Radioimmunoassays Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbexa Limited
14.1.2. Abcam Plc
14.1.3. ALPCO
14.1.4. Antigenix America, Inc.
14.1.5. Berthold Technologies GmbH & Co.KG
14.1.6. Biosynth Ltd
14.1.7. BioVendor – Laboratorni medicina a.s.
14.1.8. Creative Biomart, Inc.
14.1.9. Danaher Corporation
14.1.10. Demeditec Diagnostics GmbH
14.1.11. Diasorine S.P.A.
14.1.12. DRG International, Inc. by BioCheck Inc.
14.1.13. Drive DeVilbiss International
14.1.14. EUROIMMUN Medizinische Labordiagnostika AG
14.1.15. Hidex Oy.
14.1.16. IBL International GmbH
14.1.17. Immuno-Biological Laboratories, Inc.
14.1.18. Institute of Isotopes Co. Ltd.
14.1.19. LKB Instruments
14.1.20. LubioScience GmbH
14.1.21. Marin Biologic Laboratories, Inc.
14.1.22. Merck & Co, Inc
14.1.23. Montreal Biotech Inc.
14.1.24. MP Biomedicals, LLC
14.1.25. NovoLytix GmbH
14.1.26. Padyab Teb Co.
14.1.27. PerkinElmer Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. RADIOIMMUNOASSAYS MARKET RESEARCH PROCESS
FIGURE 2. RADIOIMMUNOASSAYS MARKET SIZE, 2023 VS 2030
FIGURE 3. RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RADIOIMMUNOASSAYS MARKET DYNAMICS
FIGURE 7. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 10. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings